Merck & Co., Inc. (MRK) stock price, chart and research
Merck & Co., Inc. (MRK) last traded at $148.76 at the close on November 9, 2026, up $2.03 (1.38%) on the day. In after-hours trading it was $148.75.
- Day range: $146.52 to $148.80
- 52-week range: $85.80 to $156.92
- Market cap: $366.73 billion
- P/E (trailing 12 months): 150.26
- Forward P/E: 16.56
- EPS (trailing 12 months): $0.99
- Dividend yield: 2.32%
- Volume: 7,557,172 shares
About Merck & Co., Inc.
Sector: Healthcare; industry: Drug Manufacturers - General; headquarters: United States; CEO: Mr. Robert M. Davis J.D.; 73,000 employees; listed since 1962-01-02.
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare,…
Financials
Revenue over the last 12 months was $67.38 billion, net income $2.45 billion, a profit margin of 3.6%. Revenue grew 4.9% from a year earlier.
Institutional owners of MRK (13F)
Tracked managers holding MRK in 13F filings for the quarter ending 2026-09-30:
- Dimensional Fund Advisors LP: $2.37 billion, 0.43% of its portfolio (reduced)
- IMC-Chicago, LLC: $17.2 million, 0.15% of its portfolio (new)
ETFs that hold MRK
- SPY: SPDR S&P 500 ETF
- XLV: Health Care Select Sector SPDR
- VOO: Vanguard S&P 500 ETF
- IVV: iShares Core S&P 500 ETF
- VTI: Vanguard Total Stock Market
- DIA: SPDR Dow Jones Industrial
- ITOT: iShares Core S&P Total US
Research MRK with LunaTerminal
- Interactive chart from one day to ten years, with volume, technicals and comparisons.
- Valuation, analyst ratings, dividends, earnings history and recent news.
- Ask LunaTerminal about MRK: AI answers that cite dated data; no account needed for 5 prompts
- 13F filings: which managers own what
- How advisors use LunaTerminal for market research
Data: Yahoo Finance via Fear & Greed (feargreedflow.com); 13F holdings from SEC filings. Market data can be delayed; check dates before relying on a figure. Answers are research, not financial advice.